Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Degarelix monthly regimen long-term safety in Chinese prostate cancer patients
CTR20140115Phase 3Completed
- Sponsor
- Ferring Pharmaceuticals
- Start
- Mar 2014
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of degarelix in prostate cancer (PCa), sponsored by Ferring Pharmaceuticals. Started Mar 2014; status: completed.
02
Drugs
degarelix
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on CTR20140115.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140115.